CD4 and neoplasm: In contrast, the low-risk group exhibited higher levels of immune cells generally associated with anti-tumor immunity, including B cells, CD8+ T cells, CD4+ T cells, M1 macrophages, neutrophils, and natural killer (NK) cells.